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Z5.5 meq/L were 3.6% and 1.9% respectively in PD-treated patients; the
corresponding risks in HD patients were 0.8% and 1.5% respectively. Hence,
we can conclude that abnormalities in serum potassium – particularly low
levels contribute disproportionately to the high death risk both cardiac and
non-cardiac in PD patients compared to those treated with HD. Whether
aggressive correction of abnormalities in serum potassium levels will reduce
death risk is presently not known but seems prudent to pursue.
http://dx.doi.org/10.1016/j.krcp.2012.04.546
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Recent studies have shown that brain-derived neurotrophic factor
(BDNF) is associated with neurotoxic, inﬂammatory and nutritional status .
The pulpose of this study is to investigate the changes in plasma BDNF
concentration that were induced by chronic uremic condition. Using an
enzyme-linked immunosorbent assay (ELISA), we measured peripheral
BDNF levels in pre-hemodialysis (pre-HD), peritoneal dialysis (PD) patients
and in a control group. The plasma BDNF concentrations of pre-HD, PD
patients were signiﬁcantly higher compared with those of controls (856.3
7 879.1, 1167.9 7 647.5 versus 403.1 7 288.9 pg/ml, respectively). The
plasma BDNF in dialysis patients was positively correlated with high-
sensitivity C reactive protein (hs-CRP) and with serum albumin negatively.
Plasma BDNF hs-CRP Albumin
r p r p
Pre-HD 0.321 0.025 -0.298 0.021
PD 0.414 0.070 -0.527 0.008
Pre-HD þ PD 0.446 0.001 -0.453 0.001
In conclusion, BDNF might plays some role in the neurotoxicity of uremia
and associated with inﬂammation and malnutrition in dialysis patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.547
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Background: Patients who are on CAPD (Continuous Ambulatory Peritoneal
Dialysis) show higher serum LDL cholesterol and Triglyceride compared to
patients who are on hemodialysis. But higher cholesterol level does not
seem to effect on raising mortality or cardiovascular morbidity and CAPD
failure. On the contrary, lower serum cholesterol level in CAPD patients
tends to raise mortality and morbidity due to poor nutritional status.
Methods: This study is a retrospective study designed to evaluate the effect
of cholesterol level, statin on CAPD outcome and mortality. Patients who
were on peritoneal dialysis for at least 6 months since March 1st, 2000
were included. A total of 467 patients were enrolled in this study. Patients’
biological parameter, biochemical parameter and morbidity/mortality
during CAPD maintenance period were collected.
Results: Patients whose initial cholesterol level were above 240 mg/dL
shows signiﬁcantly low CAPD failure rate compared to patients whose
initial cholesterol level were below 200 mg/dL (OR¼0.469, p¼0.049).
Patients whose average LDL-cholesterol during CAPD period were over
100mg/dL showed signiﬁcantly higher mortality compared to patients
whose initial LDL-cholesterol level were below 100mg/dL (OR¼1.848,
p¼0.024). Patients whose compliance to statin during CAPD period was
over 80% showed signiﬁcantly low mortality compared to patients who did
not take statin during CAPD period (OD¼0.556, p¼0.020). Patients showed
no signiﬁcant difference in motality due to total cholesterol, HDL
cholesterol levels and patients showed no signiﬁcant difference in CAPD
failure due to HDL/LDL cholesterol, statin usage.
Conclusions: Usually compared to HD or CKD patients, serum total
cholesterol level in CAPD patients was lower signiﬁcantly. However,
triglyceride level in CAPD patients was signiﬁcantly higher than CKD or HD
patient. In this study, the use of statins unrelated to cholesterol level was
signiﬁcantly effective to clinical outcomes in CAPD patients. To verify this
results the larger size and prospective study is needed.nCorresponding
author.
http://dx.doi.org/10.1016/j.krcp.2012.04.548
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More than a half of patients starting dialysis are found to have a poor
predialysis nutritional status. A low-protein diet (LPD) delays CKD
progression but occasionally lead to some changes in body composition
and malnutrition.
We performed a prospective, open-label, parallel, randomized and
controlled trial to compare a body composition and biochemical
parameters of CKD patients who were on LPD supplemented with
ketoanalogues of essential aminoacids (KA) with those on a free diet (FD).
Biochemical and bioimpedance parameters were analyzed in CKD patients
every month before initiation of dialysis. Impedance measurements were
performed with a multifrequency bioelectrical impedance analyzer. Group
I (n¼14 patients, 8 male, 6 female; 53 712 y.o; glomerular ﬁltration rate
(GFR) 18,8 7 6,3 ml/min (MDRD formula) ) having LPD (0.5 g/kg/day
protein) supplemented with KA (1 tablet/5 kg of body weight a day) was
compared with matched Group II on FD (n¼15 CKD patients with GFR
17,875,9 ml/min). Protein intake was lower in patients on LPD (0,570,1
g/kg/day protein) than on FD (1,1470,21g/kg/day; po0.0001). The
declining slopes of GFR during LPD þ KA period were signiﬁcantly lower
than those during FD, so Group I was invited to dialysis later - after
32,4712,7 months in contrast with Group II in 14,57 7,7 months
(p 0,0001). Albumin and pre-albumin levels remained stable in Group I,
but they decreased in Group II (D¼-0,9370,21 g/l, D¼-0,157
0,12g/l respectively; po0.001) at the start of dialysis. The body
composition didn’t change signiﬁcantly in patients on LPD while in patients
on FD their lean body mass decreased by 3,572,3 kg (p 0,001), body fat
mass declined by 1,5704kg (p 0,01),simultaneously extracellular water
increased þ1,570,9l, p 0,05.
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